Abstract: The missense mutation R21H in striated muscle tropomyosin is associated with hypertrophic cardiomyopathy, a genetic cardiac disease and a leading cause of sudden cardiac death in young people. Tropomyosin adopts conformation of a coiled coil which is critical for regulation of muscle contraction. In this study, we investigated the effects of the R21H mutation on the coiledcoil structure of tropomyosin and its interactions with its binding partners, tropomodulin and leiomodin. Using circular dichroism and isothermal titration calorimetry, we found that the mutation profoundly destabilized the structural integrity of aTM1a 1-28 Zip, a chimeric peptide containing the first 28 residues of tropomyosin. The mutated aTM1a 1-28 Zip was still able to interact with tropomodulin and leiomodin. However, the mutation resulted in a~30-fold decrease of aTM1a 1-28 Zip's binding affinity to leiomodin. We used a crystal structure of aTM1a 1-28 Zip that we solved at 1.5 Å resolution to study the mutation's effect in silico by means of molecular dynamics simulation. The simulation data indicated that while the mutation disrupted aTM1a 1-28 Zip's coiled-coil structure, most notably from residue Ala18 to residue His31, it may not affect the N-terminal end of tropomyosin. The drastic decrease of aTM1a 1-28 Zip's affinity to leiomodin caused by the mutation may lead to changes in the dynamics at the pointed end of thin filaments. Therefore, the R21H mutation is likely interfering with the regulation of the normal thin filament length essential for proper muscle contraction.
Introduction
Hypertrophic cardiomyopathy (HCM) is the most common monogenic inherited cardiovascular disease. [1] [2] [3] Despite the fact that it can affect people of any age, HCM is a leading cause of sudden cardiac death in people under the age of 35. [4] [5] [6] HCM is characterized by the thickening of the ventricular walls with marked myocyte disarray and varying degrees of fibrosis. 7 Many missense mutations in Tpm1.1, a striated-muscle-specific isoform of tropomyosin, 8 are associated with HCM. 9 ,10 R21H, a Tpm1.1 missense mutation, was found in DNA of HCM patients; 11 however, the molecular basis underlying its clinical manifestation remains obscure. In striated muscle, thin filaments and thick filaments constitute basic contractile units called sarcomeres. Thin filaments, composed of F-actin, are protected from severing proteins and stabilized by head-to-tail associated tropomyosin (Tpm) molecules. [12] [13] [14] Tpm is a two-stranded coiled-coil protein belonging to a multigene family. 15 Tpm is best known for its role in regulating muscle contraction. 16, 17 The N-terminal end of Tpm oriented toward the pointed end of the thin filament is crucial for Tpm's functions such as head-to-tail association, binding to F-actin and to tropomodulin (Tmod) and leiomodin (Lmod).
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The uniform lengths of thin filaments within myofibrils are maintained by Tmod and Lmod whose functions depend on Tpm. [22] [23] [24] [25] [26] Both Tmod and Lmod bind to the filament pointed end, although Lmod is also found along the sides of thin filaments. 27 Tmod acts as an efficient cap to prevent association and dissociation of actin monomers at the pointed end, 24, 28 while Lmod, a larger homolog of Tmod, acts as a leaky cap which still allows actin to polymerize at the pointed end but at a lower rate than in the absence of Lmod. 23, 26 Studies have shown both
Tmod and Lmod are critical for normal cardiac development. Tmod1, a major cardiac-specific isoform, is essential for early myofibril formation. Tmod1-null mouse embryo hearts displayed aborted myocardium development, resulting in failure to beat and pump blood and leading to early embryonic lethality. 29 Knockout of Lmod2, a major cardiacspecific Lmod isoform, resulted in shorter thin filaments followed by dilated cardiomyopathy and lethality in juvenile mice. 30 In the presence of Tpm1.1, Tmod1 and Lmod2 act together to regulate incorporation of actin monomers at the pointed end. The HCM-linked R21H mutation is located within the binding interface between Lmod2 and Tpm1. 1, 31 implying that it may have an impact on Tpm1.1's interaction with Lmod2 or Tmod1. In this study, we investigated effects of the R21H mutation on the coiled-coil conformation of aTM1a Zip, a chimeric peptide containing 28 N-terminal residues of Tpm1.1, and its interactions with Tmod1 and Lmod2. We found that the R21H mutation significantly destabilized the structure of aTM1a Zip. While the mutation did not abolish the ability of aTM1a Zip to interact with Tmod1 and Lmod2, it decreased the aTM1a 1-28 Zip's binding affinity to Lmod2 about 30-fold. We also report a crystal structure of aTM1a 1-28 Zip at 1.5 Å resolution, which is the highest resolution reported for a striated muscle tropomyosin peptide to date.
Results
The R21H mutation reduces the a-helical content of aTm1a Zip
To determine whether the R21H mutation alters the local secondary structure of Tpm1.1, we measured CD spectra of wild-type aTm1a To test whether the mutation affected the peptide's ability to form a dimer, a small amount of the mutated peptide (0.13 mg) was loaded onto a Spectra were recorded at 08C in 20 mM sodium phosphate, 100 mM NaCl, pH 7.0.
Superdex
TM 75 10/300GL gel filtration column (GE Healthcare, Little Chalfont, UK). The peptide eluted as one single peak, ruling out the possibility that there were two slowly exchanging populations of the peptide, one of which was completely folded (dimers) while the other was not (monomers).
The R21H mutation weakens the stability of aTm1a Zip and its complexes with Lmod2s1, Tmod1s1, and Tmod1s2
Observing the remarkable reduction in helical content of aTm1a Zip caused by the mutation, we next investigated how this structural change may affect the peptide's thermal stability. Thermal denaturation measurements of both wild type and mutated peptides were conducted using CD, where the ellipticity at 222 nm of each peptide was monitored as a function of temperature (Fig. 2) . During thermal denaturation, we observed a typical S-like unfolding pattern for aTm1a Zip with a clearly defined inflection point, or melting temperature (T m ), at 14.68C, which was determined at the maximum of the first derivative of the thermal unfolding curve. However, we were not able to observe the same pattern for aTm1a (Fig. 2) . These peptides are Tmod1s1, Tmod1s2, and Lmod2s1 as previously denoted. 31 Thermal stability of the complexes was evaluated based on T m values determined from the thermal denaturation curves. The wild type aTm1a 1-28 Zip peptide was able to form a complex with Tmod1s1, Tmod1s2 or Lmod2s1, since the CD spectrum of each mixture was different from the sum of CD spectra of individual peptides ( Supporting Information, Fig. S1 ). The same results were obtained using thermal denaturation measured by CD (Fig. 2) . Formation of a complex was indicated by increases in both negative ellipticity and T m . A change in T m , DT m , indicated the extent of enhanced stability as a result of complex formation. DT m values of aTm1a Zip/Tmod1s1, aTm1a Comparing T m values of the peptide complexes in the absence and presence of the R21H mutation, it was clear that the mutation significantly weakened the stability of these complexes. The thermal stability of aTm1a 1-28 Zip/Lmod2s1 complex was affected by the mutation, with T m decreasing from 32.58C to 10.88C in the presence of the mutation (Fig. 2) . The mutation also decreased T m of the aTm1a 1-28 Zip/Tmod1s1 complex from 30.48C to 7.88C (Fig. 2) . The data also indicated a decrease in T m of the aTm1a 1-28 Zip/Tmod1s2 complex in the presence of the mutation, although this difference could not be quantified.
Due to the incomplete transition recorded for aTm1a Zip[R21H], we were not able to fit its thermal unfolding curve to a two-state transition model 32 in order to calculate the peptide's enthalpy change upon unfolding. Therefore, dissociation constants characterizing the mutated peptide's binding interactions with Tmod1s1, Tmod1s2, or Lmod2s1 could not be determined by CD.
The R21H mutation profoundly decreases aTm1a Zip's binding affinity to Lmod2s1
We have shown that the mutation weakened the stability of aTm1a Zip and its complexes with Lmod2s1, Tmod1s1, and Tmod1s2 peptides. To test whether the mutation also decreased aTm1a 1-28 Zip's binding affinity for these peptides, we conducted ITC measurements, starting with the most stable complex, aTm1a Zip/Lmod2s1, as determined by CD. Lmod2s1 was used as a titrant in each measurement.
Shown in Figure 3 are ITC titrations of Lmod2s1 into aTm1a S2 ). We presumed that the binding affinity was decreased due to the mutation, hence we needed higher concentrations of the peptides for the experiment to ensure that the majority of aTm1a 1-28 Zip[R21H] was in the complex with Lmod2s1. After several trials with higher concentrations of the mutant and Lmod2s1, we were able to obtain a sigmoidal binding isotherm when 220 mM aTm1a 1-28 Zip[R21H] was titrated with 2.46 mM Lmod2s1 [ Fig. 3(B) ].
Thermodynamic parameters obtained from the curve fitting were as follows: DH 5 25.9 6 0.1 kcal/mol, DS 5 7.4 6 1.3 cal/mol/8, and N 5 0.95 6 0.01 for titrations of wild type aTm1a Zip with Lmod2s1; DH 5 210.6 6 0.1 kcal/mol, DS 5 217.3 6 0.1 cal/mol/8, and N 5 1.09 6 0.09 for titrations of aTm1a Zip[R21H] with Lmod2s1. The dissociation constant, K D , representing affinity to Lmod2s1 was determined as 0.7 6 0.1 mM for the wild type and 23.7 6 0.7 mM for the mutant. Therefore, the R21H mutation decreased the affinity of aTm1a Zip's interaction with Lmod2s1 about 30-fold.
We attempted to perform ITC titrations of Tmod1 peptides with aTm1a 1-28 Zip[R21H]. However, the binding affinities between aTm1a 1-28 Zip[R21H] and Tmod1 peptides were quite low, which required high concentrations of the mutant and Tmod1 peptides that exceeded their solubility limits.
Crystal structure of aTm1a 1-28 Zip at 1.
Å resolution
To visualize the structural effects of the R21H mutation on aTm1a Zip alone as well as on its interaction with Lmod using MDS, we first attempted to solve a crystal structure of a complex of aTm1a Zip and the Lmod peptide. However, during the process of solving crystal structure, we found that only aTm1a Zip was present in the obtained crystals. The crystals were formed in 1.5 mM sodium phosphate, pH 6.64, 0.015% sodium azide. They belonged to space group P1, with unit cell parameters a 5 35.97 Å , b 5 36.47 Å , c 5 36.71 Å , a 5 65.218, b 5 74.708, and g 5 78.988 (Table I ). The crystal structure of aTm1a Zip was determined at a resolution of 1.5 Å . Main-chain dihedral angles of all residues were within the most-favored (99.42%) or allowed (0.58%) regions of the Ramachandran plot. The peptide forms a two-stranded a-helical coiled coil [ Fig. 4(A) ].
The overall structure of aTm1a Zip is stabilized by hydrophobic core interactions and ionic interactions between residues on opposite strands. The N-terminal two-thirds of the chimeric peptide, which is composed of Tpm1.1 residues, adopts and retains the coiled-coil conformation through sidechain interactions of hydrophobic residues in the a and d positions of the heptad repeat, such as Met1, Ile4, Met8, and Leu11. From Lys15 to Asp28, the a and d positions are occupied mostly by alanines 
, where I i (hkl) is the intensity of the ith measurement of reflection hkl and hI(hkl)i is the mean value of I i (hkl) for all i measurements.
(Ala18, Ala22, and Ala25). This was referred to as one of the "alanine-staggered" regions in Tpm1.1, which may result in local bends of the coiled-coil axis. 33 The Tpm part of the coiled-coil structure of aTm1a Zip is additionally stabilized by interchain ionic interactions: salt bridges between residues Asp14 and Lys15 (Od2-Nf distance is 3.7 Å ) and salt bridges between residues Arg21 and Glu26 (Nh2-OE1 distance is 3.0 Å ). These values are similar to those in the 2.0-Å structure of Tm81 33 (PDB ID: 1IC2, chains A and B), an 81-residue N-terminal fragment of Tpm1.1, where the salt bridge distance between residues Asp14 and Lys15 (Od2-Nf distance) is 3.6 Å and between residues Arg21 and Glu26 (Nh2-OE1 distance) is 3.2 Å .
The R21H mutation induces localized changes in the coiled-coil conformation of aTm1a Figure S3 . Movements of the peptides over the entire simulations were recorded and are provided in the Supporting Information. Structures of both peptides at the final time frame and their average structures over the last 10 ns were superimposed for comparison [ Fig. 5(A, B) ].
In the presence of the mutation, the peptide lost the canonical coiled-coil structure around the mutated site, from residue Ala18 to residue His31. The average structures of the wild type and mutated peptides superimposed with RMSD of 2.6 Å calculated for Ca atoms from Ala18 to His31 (or 1.8 Å for Ca atoms from Ala3 to Val43). Interestingly, while the R21H mutation noticeably induced localized changes to the structure of aTm1a 1-28 Zip, it did not appear to affect the peptide's ends. The residues participating in formation of a salt bridge must have the distance between the centroids of oppositely charged groups of their side chains within 4 Å . 34 In wild type aTm1a Zip, the residue Arg21 on each strand forms a salt bridge with the residue Glu26 on the opposite strand (Nh2-OE1 distance is 3.0 Å ), which helps stabilize the coiled-coil conformation of the peptide [ Fig. 5(C) ]. Replacing Arg by His eliminated these local salt bridges [ Fig.  5(C) ]. In this simulation, the side chain of His21 was protonated at epsilon position, which is thought to be the most common in nature. We also ran additional simulations (data not shown) where the side chain of His21 was protonated either at delta position or at both delta and epsilon positions and obtained the same result. To investigate whether the structure of aTm1a Zip is affected when only one of the chains contains the mutation, we ran a MD simulation with a heterodimeric aTm1a 1-28 Zip[R21H] (Supporting Information, Fig. S4 ), denoted as aTm1a Zip[R21H, aa*] hereafter. The mutated heterodimer appeared to retain a canonical coiled-coil structure although one of the salt bridges formed by Arg21 and Glu26 was eliminated because of the mutation (Supporting Information, Fig. S4 ).
Discussion
The structure of aTm1a Zip reported in this study has the highest resolution among the reported crystal structures of a Tpm1.1 peptide to date, although this is not the highest resolution obtained for a tropomyosin fragment. 35 The first atomic-level structure of the N-terminus of Tpm1.1 in a chimeric peptide called TMZip was obtained using twodimensional proton NMR. 36 The sequence of TMZip contained the first 14 residues of Tpm1.1 followed by the last 18 residues of GCN4. Shortly after, the structure of Tm81, a recombinant 81-residue N-terminal fragment of Tpm1.1, was solved by X-ray crystallography at 2 Å resolution. 33 The helical coiled-coil conformation of aTm1a Zip is typical of Tpm1.1 N-terminal peptides. This was seen in the structures of TMZip 36 and Tm81. 33 Superimposition of aTm1a Zip and Tm81 structures using atomic coordinates of Ca atoms from Ala3 to Ala25 yielded a RMSD of 1.0 Å [ Fig. 4(B) ]. Superimposition of the structure of aTm1a Zip onto that of sm-Tma81, 37 an 81-residue N-terminal fragment of smooth muscle a-Tpm, yielded a slightly pronounced difference around Ala3 and Ala22, resulting in RMSD of 1.2 Å for 46 Ca positions [ Fig.  4(C) ]. There is a 158 bend of the coiled-coil axis starting from Asp28 of aTm1a Zip. This bend might result from the joining of the alaninestaggered Tpm segment (residues 15-28) and the unstaggered segment (residues 29-43) of the peptide, as previously suggested. 33 The distance between the helical axes increases from 7.5 Å in the alanine-staggered region to 8.5 Å in the remaining unstaggered, more canonical coiled-coil segments of the peptide, which is consistent with the radially smaller appearance of alanine-staggered regions in Tpm1.1 that was previously reported. 33 The CD spectrum of aTm1a Zip with large negative bands at 208 and 222 nm is typical of a polypeptide composed of mainly a-helices. Results obtained by CD and MDS indicated that the R21H mutation profoundly reduced the helical content of the peptide and created a flexible mid-region conformation. In addition, the mutant's CD melting curve showed its decreased thermal stability compared to the wild type peptide. The R21H mutation can therefore be added to a growing list of cardiomyopathy-linked mutations that affect Tpm's structural stability. [38] [39] [40] Despite the clinical evidence showing its association with HCM, the R21H mutation has not been studied elsewhere. Residue Arg21 in Tpm1.1 is conserved across species and is in the g position in the heptad repeat which is available for formation of interchain electrostatic interactions. 41 In fact, Arg21
forms a salt bridge with Glu26 in the e position of the opposite chain [ Fig. 5(C) ]. The mutation replaces a basic Arg with His which may rarely be charged at physiological pH. In MDS, regardless of the type of His21 protonation, its side chain is not long enough to form a salt bridge with Glu26. Therefore, substituting His for Arg eliminates salt bridges that otherwise provide stability to the coiled-coil structure in this region. Another missense mutation in the same residue, R21L, has been reported to be associated with HCM, 42 indicating the significance of arginine at this position. In addition to the R21H mutation, two other cardiomyopathy-linked mutations M8R 43 and K15N 44 are found within the binding interface between Lmod2 and Tpm1.1, which was localized to residues 1-21 of Tpm1.1. 31 The M8R mutation was shown to abolish the ability of Tpm to interact with Tmod1. 45 The K15N mutation had only a slight effect on Tpm1.1's N-terminal structure while causing aTm1a 1-21 Zip, a chimeric peptide containing 21 N-terminal residues of Tpm1.1, to bind to Lmod2s1 6-fold less efficiently. 31 Not only did the R21H mutation drastically destabilize aTm1a 1-28 Zip's structure, it also reduced the peptide's binding affinity to Lmod2s1 about 30-fold as determined by ITC measurements. It could be implied that either Arg21 is directly involved in binding to Lmod2s1 or the R21H mutation induces long-range effects that disrupt the binding interface between aTm1a 1-28 Zip and Lmod2s1 by increasing local flexibility in aTm1a 1-28 Zip's structure. MDS result of the aTm1a 1-28 Zip[R21H, aa*] peptide showed that the structure of the heterodimer was not very different from that of the wild type. Therefore, when only one of the two chains carried the mutation, the peptide's structure was not affected as much as it was when the mutation was present in both chains. Since the mutated heterodimer remained in a coiled-coil conformation, the mutation may not affect the heterodimer's interactions with Tmod1 and Lmod2 peptides to the same extent as it affects the homodimer's interactions.
A major part of Tpm function relies on the head-to-tail association between adjacent Tpm molecules. These overlapping regions, each ranging 9-11 residues, 46,47 determine Tpm's ability to bind actin and troponin and to regulate muscle contraction.
Our MDS data showed that the R21H mutation did not affect the ends of aTm1a Zip, which implies that the mutation might not have an effect on Tpm's head-to-tail association. However, based on our data, the mutation drastically decreases Tpm's affinity to Lmod2, thereby changing the dynamics at the pointed end of thin filaments. Thus, the R21H mutation is likely interfering with the regulation of the thin filament length critical for proper muscle contraction.
Materials and Methods

Protein sequences
Tmod1, Lmod2, and Tpm1.1 sequences were from NCBI website: NP_990358.1 (Gallus gallus), NP_997046. (Tpm-binding site 2, residues 109-146) is identical in chicken and human Tmod1.
Subcloning and site-directed mutagenesis
The DNA construct for the production of the aTM1a 1-28 Zip peptide is previously described. 31 The peptide sequence starts with a Gly residue to mimic the native N-terminal acetylation, followed by residues 1-28 of Tpm1.1 and then residues 264-281 of the GCN4 leucine zipper. Since bacterially produced Tpm usually lacks N-terminal acetylation which is crucial for Tpm's coiled-coil formation and stability, an N-terminal Gly residue allows the peptide to form a coiled-coil structure. 45 The construct for the production of the mutated peptide, aTM1a Zip[R21H], was created using site-directed mutagenesis with the plasmid pET-21b(1) encoding wild type aTM1a Zip as a template. First, the doublenicked plasmid encoding the aTM1a 1-28 Zip[R21H] peptide was generated by extending a pair of complementary oligonucleotides with the desired mutation annealed to the template plasmid in the presence of a high fidelity Pfu Turbo DNA polymerase (Agilent Technologies, Santa Clara, CA). The sense and antisense primers were 5 0 -CAA AGA AAA CGC CCT GGA TCA TGC TGA ACA GGC-3 0 and 5 0 -GCC TGT TCA GCA TGA TCC AGG GCG TTT TCT  TTG-3 0 , respectively. The primers were synthesized and purified by Integrated DNA Technologies (Coralville, IA). Following the temperature cycling, the template plasmid was digested with DpnI (New England Biolabs, Ipswich, MA). The reaction mixture was transformed into NEB V R 5-alpha Competent E. coli (High Efficiency) cells (New England Biolabs) and purified using the QIAprep V R Spin Miniprep Kit (Qiagen, Hilden, Germany). DNA sequencing of the generated construct was performed by Genewiz, Inc. (South Plainfield, NJ).
Protein expression and purification
The aTM1a Zip and aTM1a Zip[R21H] peptides were expressed in LB medium as MFH-tagged fusion proteins and purified as previously described. 31 Additionally, minor impurities were removed on a pHresistant Waters Xbridge C18 column using a linear 1% per minute gradient of 1% ammonium bicarbonate, pH 9.0 in the presence of acetonitrile. An HPLC fraction containing the major aTM1a 1-28 Zip peptide peak was neutralized with 6M HCl immediately after collection and desalted on the same column using a linear 1% per minute acetonitrile gradient in the presence of 0.1% trifluoroacetic acid. 
Isothermal titration calorimetry measurements
Isothermal titration calorimetry (ITC) experiments were conducted using MicroCal Auto-iTC 200 . Samples were dialyzed for two days in 20 mM sodium phosphate, 100 mM NaCl at pH 7.0 and centrifuged for 10 min at 13,000 rpm and 48C using Microfuge V R 18 Centrifuge (Beckman Coulter, Brea, CA) to remove any aggregates. To obtain the desired high concentrations for ITC measurements, peptide samples after dialysis were concentrated using Vivaspin V R 2 centrifugal concentrators (Vivaproducts Inc., Littleton, MA) that were pre-rinsed with the final dialysate buffer. Titrations were carried out at 48C, consisted of 1.2-to 1.3-lL injections at a rate of 0.5 lL/s, with an interval of 150 s between successive injections. The concentration of Lmod or Tmod in the syringe was about 10-to 20-fold higher than the concentration of aTm1a 1-28 Zip (wild type or mutated) in the cell. The background heat of injection was determined by titrating buffer into the cell containing aTm1a 1-28 Zip (wild type or mutated). For each experiment, the heat of binding was corrected for the heat of injection. Data analysis was performed using the Origin V R software (OriginLab Corporation, Northampton, MA).
Crystallization
The aTM1a Zip and Lmod peptides were dissolved in 1.5 mM sodium phosphate, pH 6.64, 0.015% sodium azide and centrifuged at 14,000 rpm using Microfuge V R 18 Centrifuge (Beckman Coulter, Brea, CA) for 5 min to remove any possible aggregates. The final peptide concentration was 17.5 mg/ mL. Screening was carried out by the sitting-drop vapor-diffusion method (150 nL protein solution mixed with 150 nL reservoir solution and equilibrated against 120 mL reservoir solution) at 293 K in 96-well plates using a Mosquito crystal nanolitre liquid handler (TTP LabTech) and the following screening kits: Crystal Screen (Hampton Research), Wizard Classic I and II, and Cryo I (Rigaku Reagents). Crystals were obtained using condition No. 21 of Wizard Classic I (20% (w/v) PEG 8000, 100 mM HEPES/sodium hydroxide, pH 7.5).
Data collection and 3D structure determination
The crystals were mounted on a cryo-loop and flashcooled in liquid nitrogen. X-ray diffraction data were collected using synchrotron radiation (wavelength 1 Å ) and PILATUS 6MF detector on beamline X06SA at PSI, Swiss. All images were collected at 100 K using a 0.18 oscillation angle per frame.
The datasets were processed and scaled using the XDS program package. 51 The initial structure was obtained by molecular replacement in PHASER 52 from PHENIX package 53 using chimeric model made manually based on homology models calculated by PHYRE2. 54 The molecular replacement solution was re-built using BUCCANEER 55 from CCP4 package 56 and improved through manual building and corrections in COOT 57 and iterative rounds of refinement in PHENIX. Crystal structure revealed the presence of aTM1a Zip only.
Molecular dynamics simulations
The crystal structure of aTm1a 59 Hydrogen atoms were first added based on the availability of bond angles. The peptide was then placed in a simulated box of TIP3P water molecules with a 10 Å minimal distance from the outermost sidechains to the edge of the box. The charge of the protein was neutralized by adding Na 1 ions in the protein-water simulated box. The system was energy-minimized to overcome the effects of steric overlap between atoms. The motion of each peptide was simulated as a function of time using the SHAKE algorithm 60 with a time step of 2 fs. The simulations were run at 08C for 80 ns in order to reach pseudo-steady states. RMSD calculations were made using CPPTRAJ. 61 
